News – Page 109 – Endpoints News

BioMarin shakes up executive team, tapping notable dealmaker James Sabry

8 months ago

WuXi Bio spotlights new US contracts, but profits are down as Biosecure brews

8 months ago

Timber Pharmaceuticals' candidate for rare skin disorder flunks all endpoints in late-stage trial

8 months ago

Indian CDMOs unlikely to see sudden surge in clients if China bill passes, execs say

8 months ago

FDA rejects Regeneron’s multiple myeloma bispecific antibody over manufacturing issues

8 months ago

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

8 months ago

BridgeBio forms another offshoot with $300M in commitments

8 months ago

Dr. Reddy's and Stanford spinout Kainomyx partner up on anti-malarial program

8 months ago

Aadi says its solid tumor drug is unlikely to succeed, winding down the trial and axing staffers

8 months ago

After Pfizer layoffs, Array chemists regather at next-gen obesity biotech Ambrosia Biosciences

8 months ago

Semaglutide may come with a higher risk of suicidal thoughts, JAMA study finds

8 months ago

WuXi Biologics’ ADC spinout reports revenue jump despite Biosecure risk

8 months ago

J&J scores approval for Rybrevant combo in first-line lung cancer, stoking rivalry with Tagrisso

8 months ago

Lawsuit alleges Biogen schemed with PBMs to preserve Tecfidera market

8 months ago

FTC backs FDA plan to remove switching study requirement for interchangeable biosimilars

8 months ago

Emergent joins broader efforts for mpox vaccine drive in Africa

8 months ago

House lawmakers call on FDA to investigate clinical trials run alongside China's military

8 months ago

Kymera seeks to raise $225M; Adcendo, Multitude's new ADC deal

8 months ago

Big employers are spending even more money on pharmacy costs, driven by GLP-1s and other high-cost therapies, survey ...

8 months ago

TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease

8 months ago

J&J buys another medtech company, this time paying $600M upfront for Israel-based V-Wave

8 months ago

Merck rejigs ADC deal with Kelun, grabbing one program and returning another

9 months ago

Lilly says tirzepatide kept obese and overweight people from developing diabetes

9 months ago

Half of IRA negotiation savings to come from three drugs, Brookings finds

9 months ago

First page Previous page 106 107 108109110 111 112 Next page Last page